금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Reports of US-Iran ceasefire deal, sinks Oil – RIA Novosti
The Russian agency RIA Novosti reported that Washington and Tehran agreed to a ceasefire, citing sou...
US Treasury yields fall as Hormuz progress eases inflation fears
US yields edge lower across the whole curve on Tuesday, following suit....
Stock Market Today: Nasdaq Reverses Higher; Ciena Slammed, But Banks Rebound (Live Coverage)
The Dow Jones index rises and the Nasdaq turns higher. But Broadcom, Ciena and CrowdStrike plunge on earnings.
3 Reasons to Sell KAI and 1 Stock to Buy Instead
Kadant trades at $311.98 and has moved in lockstep with the market. Its shares have returned 7.2% over the last six months while the S&P 500 has gained 11%.
Hyliion jumps to a new 52-week high as investors eye the data center business potential
Anthropic assists US security agency’s use of Mythos for cyber attacks
Arrangement with NSA comes as AI lab is locked in legal battle with Pentagon over Claude model
PVH expects $11.80-$12.10 EPS and flat full-year revenue while factoring in Middle East conflict and $100M tariff refunds
'AI exceptionalism' spreads beyond U.S.
Expro's redomicile to Cayman Islands backed by ISS in reversal; Goldman raises to Buy
Historic U.S.-Japan $1B deal targets AI, Quantum, Fusion: These stocks to watch
WTI declines as Israel-Lebanon ceasefire eases tensions in the Middle East
West Texas Intermediate (WTI) Crude Oil slips nearly 3% on Thursday as market sentiment improves following a ceasefire agreement between Israel and Lebanon. At the time of writing, WTI trades around $ ...
2 Financials Stocks to Target This Week and 1 We Turn Down
Financial firms serve as the backbone of the economy, providing essential services from lending and investment management to risk management and payment processing. Still, investors are uneasy as comp ...
American Express Card Spending Is Growing at Its Fastest Pace in 3 Years. Can the Affluent Consumer Keep It Up?
Despite solid fundamentals, the credit card company's shares have fallen double digits in 2026.
Alvotech seeks U.S. nod for biosimilars to J&J’s Simponi and Regeneron’s Eylea again